chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 5 minutes after administering a series of vaccines for two month old (Prevnar, Pentacel, Hepatitis B & Rotavirus), baby appeared pale, cyanotic, limp. Dr. administered EpiPen, Jr. Within seconds, the baby cried, remained pale but appeared to be breathing. Auscultation confirmed Heart RRR & Lungs CTA B/L. He remained pale, slightly drowsy. O2 administered by Nasal Cannula @ 2L/min. Within minutes, rescue team arrived and transported baby to E.D. in stable condition.
Subsequent to receiving one dose of varicella virus vaccine live, on 1/15/98, the pt developed chickenpox on 4/21/99 that consisted of more than 200 pox. The pt was seen by a physician.
case vaccinated on 8/7/21. Tested positive for covid on 11/01/2021. Admitted to Medical Center on 11/01/2021. Expired on 11/4/2021 while still hospitalized.
This spontaneous report was received from a healthcare worker and refers to multiple unspecified patients of unknown age and gender. No information regarding the patients' pertinent medical history and drug reactions or allergies was provided. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX injection (exact dose, lot #, expiration date and route of administration were not reported). The vaccines were reconstituted with properly stored sterile diluent (MERCK) injection. The reporter stated that the administered doses of VARIVAX were stored at the temperature between 15 degrees Fahrenheit to 46 degrees Fahrenheit for 42 minutes on an unknown date. Data logger was used to detect this temperature excursion. There was no previous temperature excursions reported. No adverse effects were reported. No product quality complaint was involved. This is one of three reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1709USA012904: US-009507513-1709USA012903.
Within 10 days after vaccine #2, I developed extreme dizziness and bilateral lymph node pain. Both of these adverse effects are still occurring. to date. Went to see ENT to rule out vertigo with dizziness which he did - not vertigo. Have also reported lymph node pain to my GP, and NP.
received 1st dose of Shingrix 2.5 to 3 years ago / is late for the 2nd dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on unknown date 2.5-3 years prior to reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follows:  The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. No symptoms were was reported. The healtcare professional (HCP) stated that the patient received 1st dose of the vaccine at a his doctor's office. The HCP did not have the lot and expiration date. The reporter consented to follow up. This case has been linked with US2021100489, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021100489:same reporter
At 0130 hours, i experienced fever, shivers, chills, muscle and joint aches. I also experienced loss of taste, headache. The body aches, headaches continued throughout the day while fever decreased.  Occasional shivers/ chills also continued. Severe lethargy and exhaustion along with neck pain and mild headache.
horrible pain in her shoulder; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558).  A female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1st), for COVID-19 immunization. The following information was reported: ARTHRALGIA (non-serious), outcome "unknown", described as "horrible pain in her shoulder". Therapeutic measures were taken as a result of arthralgia.  Additional information: Reporter stated 5 days after receiving the second dose her mother had horrible pain in her shoulder and took Tylenol. Reporter asked if her mother could take Tylenol after receiving the booster dose.   Follow-up: This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Urticarial eruption < 1 hour after immunizations.  No respiratory symptoms noted.  Vaccination site was without inflammation.  Trunk, neck and face covered with hives.  Also some hives on hands.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 21-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: METOPROLOL. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 which includes Paxlovid from 31Jul2023 to 04Aug2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever, muscle pain, migraine-like headache, spine pain. Treated with Imitrex for headache and Advil for other pain.
In the face sensation in my mouth like anesthesia from a dentist difficult to breathe my nose was completely stuffed up I had to go to the emergency room.
Got the three vaccines in left arm and that night had pain and redness and had temperature of 102F.  Woke up with pain in arm and rash going down to elbow. Rash has continued down arm and felt itching up until today.
Local reaction, swollen redness induration at DTAP site extended from upper arm to elbow
I had some fatigue the first couple of days but nothing that kept me from going to work - just took it slower and easier those days. The tinnitus started on 19th - ear pain on the right ear. I woke up that morning, I had pain. When I touched it I had pain on the front of my right ear.  ( It appears to be coming from my right ear.) I took some Zyrtec D to see if that would help me and I took that for two days and that seemed to help but then the ringing started. I notice it more at night when it's quiet or when I'm working myself doing my maintenance work at rental units. I thought it was clogging of ear and so I was going to go to the doctor but I did ear drops and flushed for two days. It didn't subside anything with the ringing - I might be able to hear a little better. I don't have pain anymore as to the touch but I still have the tinnitus - the ringing in the ear - that constant sound. It has been continuing it seems to not be as bad but others it is. When I go to bed or when I wake up at night the ringing there it's hard to go back to sleep. I have an appt with the Ears, nose and throat doctor. My hearing doesn't seem to be affected, but I can't say for sure if it's any different - I'm left handed so I use my left ear in the phone.
I awoke at 3am with splitting headache. Took a Tylonol and went back to bed. In the morning I awoke with headache, body aches, temperature of 100.3 and very fatigued. After eating something I went back to bed until dinner time. The next day I felt fine. The day later, 2/16/21, I again had the same symptoms but milder and again slept most of the day. Since then the mild headache and fatigue have returned everyday in the late afternoon until a week ago, April 1, 2021. On March 24, I visited Dr. on another issue and asked if my symptoms could be a residual from the vaccine. He said yes and I told me to report my symptoms on this site. I no longer have any lingering symptoms.
This spontaneous report was received from a registered nurse referring to a multiple unspecified patients of unknown age and gender. On an unknown date the patients were vaccinated with incorrectly stored doses of (Oka-Merck) PROQUAD (dose and route of vaccination were not reported, lot # L017140 with expiration date: 13-NOV-2016, lot # K025760 with expiration date: 08-JAN-2016, lot # reported as L021599 with expiration date: 10-DEC-2016). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Drowsiness slept for 11 hours straight.  Decreased appetitie, hypersomnolence for 2 days.
Pt called in to report after receiving ADACEL on 7/27/11 felt fatigue & generalized muscle & joint aches, 7/28 Temp 99. Lasted x 1 day.
I very rapidly lost consciousness and fainted.  This happened 3 times in a 10 minute period as I was alone and unaware at the time of what was happening. My husband witnessed the third episode. My heart was racing at this time and I had broken out into a full sweat. After getting me into bed, with cold compress applied to my forehead, my symptoms seemed to resolve.  We called my physician the next morning and they had me go into the office for a follow-up the following week.  They diagnosed me with a concussion from repeatedly falling and hitting my head.
consumer reports that daughter exp pain in the wrists, hips, & ankles & partial paralysis 10 days p/vax; MD dx peripheral polyneuropahty demyelineating in nature, affecting sensory & motor fibers consistent w/chronic inflam polyneuropathy;
Pt vaccinated with Recombivax HB developed fever, chills, fatigue, nausea, & vomiting which progressed to peritonitis. Was hospitalized for an unknown time, & discharged. Now undergoing test for Epstein-Barr virus infection.
Pt states she recrived flu vaccine on 10/24/20 and is still continuing to have injection site redness, tenderness to touch, and feels "hot" as of 10/26/20. States that site redness is "golf ball" size.
Unsure of exact times. Stated everything was fine, but over the weekend she started having problems with her breathing. On 8/29/2013 she called our nurse triage line and stated she could not take a full deep breathe, funny feeling in the back of her throat and chest area. She was advised to seek medical treatment. Disposition unknown at this time.
WITHIN A FEW MONTHS OF GETTING THE VACCINE, I BEGIN TO HAVE HEART PROBLEMS. MY HEART RATE STAYED VERY RAPID, I WAS DIZZY, FATIGUED, AND HAD EPISODES OF PASSING OUT. I HAVE SINCE BEEN DIAGNOSED WITH POTS. I HAVE ALSO BEEN DIAGNOSED WITH AUTOIMMUNE PANCREATITIS, HAD MY ENTIRE SIGMOID COLON REMOVED, BEEN ON 28 ANTIBIOTICS DUE TO GUT ABSCESSES, HAD 3 MRIS, AND NUMEROUS CT SCANS. SINCE 06/14/2021, I HAVE BEEN IN THE HOSPITAL EVERY MONTH FOR EITHER AN ER VISIT DUE TO ABSCESS AND EXTREME PAIN, OR FOR WEEK LONG HOSPITAL STAYS DUE TO NEEDING AN NG TUBE, PAIN MANAGEMENT, BOWEL PERFORATIONS, ETC. I HAVE HAD TO QUIT WORKING MY LONG TIME CAREER AS A CERTIFIED NURSING ASSISTANT AND NOW WORK FROM HOME AS I AM SO FATIGUED AND WEAK FROM ALWAYS BEING SICK.
Condition aggravated; Palpitations; Tinnitus; This case was received on 01-Jun-2021 and was forwarded to Moderna on 01-Jun-2021.    This regulatory authority case was reported by an other health care professional and describes the occurrence of CONDITION AGGRAVATED (Condition aggravated), PALPITATIONS (Palpitations) and TINNITUS (Tinnitus) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Asthma and Allergy NOS. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) and LOSARTAN for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced CONDITION AGGRAVATED (Condition aggravated) (seriousness criterion disability), PALPITATIONS (Palpitations) (seriousness criterion disability) and TINNITUS (Tinnitus) (seriousness criterion disability). At the time of the report, CONDITION AGGRAVATED (Condition aggravated), PALPITATIONS (Palpitations) and TINNITUS (Tinnitus) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Immediately upon receiving injection, the patient's heart began racing, and what had been a relatively quite ringing in his ears for the past year or two, also immediately became 2-3x louder (maybe even more), where it had remained ever since (nearly 2 months). The heart rate settled down within a few second, but the ringing persisted, and continued. Before the vaccine, the ringing was a very high pitched, constant tone, like the high pitched tone he used to hear on an airplane sometimes, but it was so quiet that he only noticed when he would wake up in the morning or at other random times when everything around him was very quiet. Since the vaccine, however, it became loud enough that it was impossible not to notice it constantly; not so loud that he could not hear other things around him or people talking, but definitely loud enough that it was unmistakably there and could at times be a real distraction to focus and even conversation.  Treatment medications were not reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
arm was sore for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (arm was sore for a couple of days) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (arm was sore for a couple of days). At the time of the report, MYALGIA (arm was sore for a couple of days) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-016969, MOD21-081941 (E2B Linked Report). This case was linked to MOD-2021-090431 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-016969: MOD21-081941:
Patient received 2nd Moderna vaccine at 1145.  At approximately 1157 patient complained of feeling dizzy and chest discomfort.  BP 160/82, pulse 81 and regular.  At 1204 BP 151/93, pulse 78.  At 1209 patient complained of increased dizziness and chest pain.  BP 165/105, pulse 86.  Patient was taken to ED.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On 10-SEP-2018, the patient was vaccinated with an improperly stored dose of VAQTA (dose and route were unknown) lot # R012740 expiration date 09-AUG-2019 for prophylaxis. This was the first temperature excursion. No Digital Data Logger as involved. This is one of several reports received from the same source. Sender's Comments: US-009507513-1809USA011220: US-009507513-1809USA011221.
erythema, induration 3" x 2", pruritus& tenderness lt arm;
11-5-21 I GOT MY BOOSTER SHOT IN MY ARM  ON 12-3-21 I STARTED TO GET A NUMBING FEELING IN MY RIGHT HAND TO WHERE LIKEIT IS ASLEEP ITS NOT A REALLY GOOD FEELING IT HURTS AND I CANT SLEEP BARELY AT NIGHT CUZ IT WILL START TO GO NUMB THIS STARTED AFTER MY BOOSTER SHOT
Pericarditis associated with chest pain,  elevated troponin and BNP. Confirmed by cardiac MRI. Symptoms started 1-2 weeks following administration of dose #2.
This spontaneous report as received from a medical assistant refers to patients of unknown age and gender. No pertinent medical history and drug reactions or allergies were reported. On an unknown date the patients were vaccinated with improperly stored RECOMBIVAX HB (lot number and expiry date unknown) (dosing regimen and frequency unknown) for an unknown indication. No concomitant medications were reported. No adverse events were reported. The action taken with the therapy with RECOMBIVAX HB was unknown. The outcome of the events was unknown. The relatedness of the events to the therapy with RECOMBIVAX HB was unknown. There was no product quality issue reported. This is one of the many reports from the same source. Additional information has been requested.
Never had a problem before.  This time, my arm was stiff, not uncommon...however 2 days later, I IMMEDIATELY woke up and was unable to walk.  My hips felt like I had run a 20 mile marathon.  I was so stiff that, I had to use my hands to lift my legs.  Went to chiropractor for a few sessions, felt alittle relief...but it is STILL not good.  Feel like I have MS or something.  Went to my family doctor last week, he ordered tests and blood work.
This case was reported by a consumer and described the occurrence of mental fogginess in a 2 month old female subject who was vaccinated with combined diphtheria and tetanus toxoids and acellular pertussis absorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined for prophylaxis. The reporter is the subject's father. A physician or other health care professional has not verified this report. Previous and/or concurrent vaccinations included combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliomyelitis vaccine given on 5/05 and 7/05. Medical history noted the subject has a male twin who also received Pediarix at 2-4-6 months; however, no personality change was noted with any Pediarix vaccinations. On an unspecified date in March 2005, the subject received first dose of Pediarix (lot number not specified). Concurrently, the subject also received injections of influenza virus vaccine and 7-valent pneumococcal conjugate vaccine. On an unspecified date in March 2005, at an unspecified time after vaccination with Pediarix, the subject experienced mental fogginess. The father stated his daughter was in a fog after vaccination with Pediarix. The father reported that his daughter continued to receive Pediarix at both the 4 (May 2005) and 6 (July 2005 month intervals. This case was assessed as medically serious (OMIC). At the time of reporting, on 7/25/05, the event was resolved.
pt feels lt hand is swollen 3x the size of the rt hand, however no swelling observed by school nurse; 13APR95 arm & hand feels numb;
Initial report received from a healthcare professional on 09 April 2013 and follow up information received from other company (Merck) on 24 April 2013. Other company reference number: 1-6856855155. A patient, whose age, gender, medical history and concomitant medications were not reported, had received a dose of ActHIB vaccine (lot number, dose number, route and site of vaccination were not reported) on an unspecified date. It was reported that the patient was administered ActHIB vaccine and some of the vaccine leaked out of the syringe. Thus the patient received a vaccine under dose. As of 09 April 2013, the patient had no adverse event. List of documents held by sender: none.
soreness; This is a spontaneous report from a contactable consumer or other non hcp (niece's brother in law). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date as UNK, single (SINGLE DOSE) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced soreness on an unspecified date. The reporter stated the patient took the first shot and had some soreness and then took the 2nd shot and was so sick, feeling like he had the flu and other symptoms. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
3 minute span, 7 minutes into 15 minute post vaccine wait... BP dropped to 68/57..  pale, dry, blue lips...  visual disturbance...  nausea, dry heaves, dizzy, close to fainting... left side of body has more color than right side....  BP returned to 100/71 within 2 minutes...  coherent throughout
Patient started to have a headache and feel dizzy after injections, patient wanted to try to make it to the car, but fainted outside the building.  Mom was able to catch her, no s/s of harm.
Both ears with pressure and pain further past ear canal. Hearing is loss. Hearing is as if have a cold, but no cold present.   04/27/2021 Around noon random migraine attacks through out day.
patient received Moderna bivalent booster doses that had undergone a temperature excursion; dose were administered before it was known if the vaccine was ok to use after the excursion; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patient received Moderna bivalent booster doses that had undergone a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (dose were administered before it was known if the vaccine was ok to use after the excursion) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patient received Moderna bivalent booster doses that had undergone a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (dose were administered before it was known if the vaccine was ok to use after the excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patient received Moderna bivalent booster doses that had undergone a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (dose were administered before it was known if the vaccine was ok to use after the excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (patient received Moderna bivalent booster doses that had undergone a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (dose were administered before it was known if the vaccine was ok to use after the excursion).    This case was related to patient number 48 out of 77.  No concomitant medication information provided. No treatment information provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-696122.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-696122:Master case